← Leaderboards
Chester Edward Markwalter
Optimeos Life Sciences, Inc.
$577,676
Attributed
$855,351
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $300K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$855,351 · 3
By mechanism
R43$855,351 · 3
Top collaborators
- Allen Chung1 shared
- Joseph Benjamin Rucker1 shared
Most similar at Optimeos Life Sciences, Inc.
Same institution · by research overlap
- Robert Frederick Pagels$287,726
- Allen Chung$150,000
Others in their field
Other Emerging Leaders on “Encapsulated”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Norbert Pardi · University Of Pennsylvania$9,632,548
- Anthony Philippakis · University Of California Santa Cruz$8,233,333
- Benedict Paten · University Of California Santa Cruz$8,233,333
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$7,356,765
- Rachael W Sirianni · Arizona State University-Tempe Campus$7,186,838
Research focus
EncapsulatedDoseStructureExhibitsDesignNanoparticlePerformanceSmall Business Innovation Research GrantFormulationTechnologyPolymersIn VivoAntibodiesLipid NanoparticleLigandsIn VitroLeadLipidsBiological SciencesImmuneInflammationHybridsAffectCost
Grant awards (3)
In vivo targeted delivery of nucleic acids to hematopoietic stem cells for treating primary immunodeficiencies$300,000
R43 · FY2025 · AI
Targeted delivery of nucleic acid formulations for in vivo CAR-Treg generation$300,000
R43 · FY2024 · AI · contact PI
Sustained Release Formulations of Therapeutic Antibodies$255,351
R43 · FY2021 · GM · contact PI